BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15714519)

  • 1. Validation of dye-binding/high-resolution thermal denaturation for the identification of mutations in the SLC22A5 gene.
    Dobrowolski SF; McKinney JT; Amat di San Filippo C; Giak Sim K; Wilcken B; Longo N
    Hum Mutat; 2005 Mar; 25(3):306-13. PubMed ID: 15714519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.
    Wang Y; Kelly MA; Cowan TM; Longo N
    Hum Mutat; 2000; 15(3):238-45. PubMed ID: 10679939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological rescue of carnitine transport in primary carnitine deficiency.
    Amat di San Filippo C; Pasquali M; Longo N
    Hum Mutat; 2006 Jun; 27(6):513-23. PubMed ID: 16652335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation.
    Wang Y; Taroni F; Garavaglia B; Longo N
    Hum Mutat; 2000 Nov; 16(5):401-7. PubMed ID: 11058897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency.
    Li FY; El-Hattab AW; Bawle EV; Boles RG; Schmitt ES; Scaglia F; Wong LJ
    Hum Mutat; 2010 Aug; 31(8):E1632-51. PubMed ID: 20574985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.
    Iacobazzi V; Invernizzi F; Baratta S; Pons R; Chung W; Garavaglia B; Dionisi-Vici C; Ribes A; Parini R; Huertas MD; Roldan S; Lauria G; Palmieri F; Taroni F
    Hum Mutat; 2004 Oct; 24(4):312-20. PubMed ID: 15365988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality.
    Burwinkel B; Kreuder J; Schweitzer S; Vorgerd M; Gempel K; Gerbitz KD; Kilimann MW
    Biochem Biophys Res Commun; 1999 Aug; 261(2):484-7. PubMed ID: 10425211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency.
    Mayatepek E; Nezu J; Tamai I; Oku A; Katsura M; Shimane M; Tsuji A
    Hum Mutat; 2000 Jan; 15(1):118. PubMed ID: 10612840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter.
    Nezu J; Tamai I; Oku A; Ohashi R; Yabuuchi H; Hashimoto N; Nikaido H; Sai Y; Koizumi A; Shoji Y; Takada G; Matsuishi T; Yoshino M; Kato H; Ohura T; Tsujimoto G; Hayakawa J; Shimane M; Tsuji A
    Nat Genet; 1999 Jan; 21(1):91-4. PubMed ID: 9916797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients.
    Tang NL; Hwu WL; Chan RT; Law LK; Fung LM; Zhang WM
    Hum Mutat; 2002 Sep; 20(3):232. PubMed ID: 12204000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype correlation in primary carnitine deficiency.
    Rose EC; di San Filippo CA; Ndukwe Erlingsson UC; Ardon O; Pasquali M; Longo N
    Hum Mutat; 2012 Jan; 33(1):118-23. PubMed ID: 21922592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
    Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
    Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyopathy and carnitine deficiency.
    Amat di San Filippo C; Taylor MR; Mestroni L; Botto LD; Longo N
    Mol Genet Metab; 2008 Jun; 94(2):162-6. PubMed ID: 18337137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
    Shabbeer J; Robinson M; Desnick RJ
    Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype and genotype variation in primary carnitine deficiency.
    Wang Y; Korman SH; Ye J; Gargus JJ; Gutman A; Taroni F; Garavaglia B; Longo N
    Genet Med; 2001; 3(6):387-92. PubMed ID: 11715001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and molecular studies in primary carnitine deficiency.
    Frigeni M; Balakrishnan B; Yin X; Calderon FRO; Mao R; Pasquali M; Longo N
    Hum Mutat; 2017 Dec; 38(12):1684-1699. PubMed ID: 28841266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC22A5 mutations in a patient with systemic primary carnitine deficiency: the first Korean case confirmed by biochemical and molecular investigation.
    Yoon YA; Lee DH; Ki CS; Lee SY; Kim JW; Lee YW; Park HD
    Ann Clin Lab Sci; 2012; 42(4):424-8. PubMed ID: 23090741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.
    Lamhonwah AM; Olpin SE; Pollitt RJ; Vianey-Saban C; Divry P; Guffon N; Besley GT; Onizuka R; De Meirleir LJ; Cvitanovic-Sojat L; Baric I; Dionisi-Vici C; Fumic K; Maradin M; Tein I
    Am J Med Genet; 2002 Aug; 111(3):271-84. PubMed ID: 12210323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of congenital goitres with hypothyroidism caused by defective thyroglobulin synthesis. Identification of a novel c.7006C>T [p.R2317X] mutation and expression of minigenes containing nonsense mutations in exon 7.
    Machiavelli GA; Caputo M; Rivolta CM; Olcese MC; Gruñeiro-Papendieck L; Chiesa A; González-Sarmiento R; Targovnik HM
    Clin Endocrinol (Oxf); 2010 Jan; 72(1):112-21. PubMed ID: 19438905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.